Small Stocks, Big Money

SCAP Portfolio Manager Jay Hatfield’s Market Playbook: Fed Cuts, Core PCE, and Small Caps

07 Apr 2026

Contributed by Lukas

In our exclusive interview, Jay Hatfield (Founder, CEO, and Portfolio Manager at InfraCap) outlines a disciplined approach to small-cap investing buil...

Enlivex (Nasdaq: ENLV) - FY25 Financial Results Webcast Replay

31 Mar 2026

Contributed by Lukas

Watch our replay of Enlivex’s FY25 Financial Results Webcast to hear management discuss the company’s outlook, financial performance, and its diff...

Enlivex (ENLV) CEO: Two Pillars of Growth, Allocetra Knee OA Catalyst + RAIN Treasury Optionality

24 Mar 2026

Contributed by Lukas

Enlivex (Nasdaq: ENLV) CEO Oren Hershkovitz breaks down the company’s two-pillar strategy designed to build shareholder value through both biotech e...

Off The Hook (NYSE American: OTH) CEO Interview: $145M Revenue Path, AI Boat Platform, Apex Upside

17 Mar 2026

Contributed by Lukas

Off The Hook (NYSE American: OTH) CEO Brian John joins us for an exclusive interview to break down what makes OTH different from a traditional boat de...

Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth

10 Mar 2026

Contributed by Lukas

What makes Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) a story investors should be watching right now?In our exclusive interview, Chri...

The Metals Company (TMC) CFO Craig Shesky: The NOAA Path, $23.6B NPV, and US Supply Security

03 Mar 2026

Contributed by Lukas

​  @themetalscompany  (Nasdaq: TMC) is a developer of lower-impact critical metals from seafloor polymetallic nodules, on a dual mission: (1) supp...

BioVie (Nasdaq: BIVI) CEO Cuong Do on Near Term Catalysts in Parkinson’s, Long COVID, and Ascites

24 Feb 2026

Contributed by Lukas

BioVie (Nasdaq: BIVI) President and CEO Cuong Do joins us for an exclusive investor interview discussing BioVie’s late-clinical-stage pipeline and u...

First Phosphate CEO John Passalacqua: Building a North American LFP Battery Supply Chain (FRSPF)

17 Feb 2026

Contributed by Lukas

Lithium iron phosphate (LFP) batteries now power the majority of global battery production, but supply chains remain heavily concentrated in Asia. In ...

Nexalin Technology (NXL) CEO Mark White: FDA Trials, At-Home Neurostimulation, and 2026 Milestones

10 Feb 2026

Contributed by Lukas

In our investor-focused interview, Mark White, CEO of Nexalin Technology (Nasdaq: NXL), breaks down how the company is building a non-invasive neurost...

OBOOK Holdings (OWLS) CEO Darren Wang on Regulated Stablecoin Payments, OwlPay Growth and 2026 Goals

03 Feb 2026

Contributed by Lukas

Darren Wang, Founder, Chairman, and CEO of OBOOK Holdings (Nasdaq: OWLS), joins us to discuss how OwlTing is building a compliance-first stablecoin an...

NioCorp (NB) CEO Mark Smith on 2025 Milestones, Elk Creek Portal Buildout, and U.S. EXIM Financing

27 Jan 2026

Contributed by Lukas

NioCorp (Nasdaq: NB) CEO Mark Smith joins us to break down a milestone year for the Elk Creek Critical Minerals Project in Nebraska and what could be ...

ASP Isotopes (Nasdaq: ASPI) Investor Webinar - January 14, 2026

20 Jan 2026

Contributed by Lukas

Join  @RedChip  for an investor Q&A webinar with ASP Isotopes (Nasdaq: ASPI) Executive Chairman and CEO Paul Mann, covering ASPI’s transition ...

Avalon Advanced Materials CEO Interview | $4B Lithium Opportunity + Rare Earth Supply Chain Upside

13 Jan 2026

Contributed by Lukas

In our in-depth interview, Scott Monteith, CEO of Avalon Advanced Materials (OTCQB: AVLNF), breaks down why Avalon is emerging as one of North America...

Alliance Entertainment (NASDAQ: AENT) Chairman on Earnings Growth and Exclusive IP Strategy

06 Jan 2026

Contributed by Lukas

In this exclusive interview, Bruce Ogilvie, Executive Chairman of Alliance Entertainment (NASDAQ: AENT), outlines the company’s strategy to drive su...

Processa Pharmaceuticals (PCSA) Interview: Phase 2 Breast Cancer Data, Pipeline Strategy & FDA Path

23 Dec 2025

Contributed by Lukas

In this exclusive interview, David Young, PhD, President of Research & Development and Founder of Processa Pharmaceuticals (Nasdaq: PCSA), breaks ...

New Era (Nasdaq: NUAI) CEO Discusses Power, AI Data Centers, and the Next Phase of Growth

16 Dec 2025

Contributed by Lukas

In this exclusive interview, E. Will Gray II, Chairman, CEO, and Interim CFO of New Era Energy & Digital (Nasdaq: NUAI), breaks down the company’...

NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress

09 Dec 2025

Contributed by Lukas

In our in-depth interview, NioCorp (Nasdaq: NB) CEO Mark Smith discusses the rapidly evolving landscape for U.S. critical minerals and the company’s...

Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource

02 Dec 2025

Contributed by Lukas

📌 In our exclusive interview, Nova Minerals (Nasdaq: NVA) CEO Chris Gerteisen breaks down the company’s rapid transformation into a U.S. critical...

BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs

25 Nov 2025

Contributed by Lukas

In this exclusive interview, BullFrog AI (Nasdaq: BFRG) CEO Vin Singh discusses how the company’s proprietary bfLEAP™ AI platform and BullFrog Dat...

Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech

18 Nov 2025

Contributed by Lukas

Jackpot Digital (OTCQB: JPOTF | TSXV: JJ) CEO Jake Kalpakian discusses how the company’s flagship Jackpot Blitz® platform is redefining casino poke...

Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy

11 Nov 2025

Contributed by Lukas

🚀 Connect Biopharma (Nasdaq: CNTB) is advancing rademikibart, a next-generation biologic designed to redefine how asthma and COPD are treated — t...

FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity

04 Nov 2025

Contributed by Lukas

📊 FatPipe Networks (Nasdaq: FATN) — a pioneer in mission-critical networking and cybersecurity — is driving strong profitability and growth in ...

60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead

28 Oct 2025

Contributed by Lukas

💡 60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoff Dow discusses the company’s mission to tackle infectious diseases with unmet medical needs ...

Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon

21 Oct 2025

Contributed by Lukas

🔋 Bimergen Energy (OTCQB: BESS) is emerging as a major player in the booming U.S. battery energy storage sector—and CFO Bob Brilon shares how the...

Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next!

14 Oct 2025

Contributed by Lukas

Mark White, CEO of Nexalin Technology (Nasdaq: NXL), joins us to discuss how Nexalin aims to simplify and make mental health care more accessible with...

Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development

07 Oct 2025

Contributed by Lukas

Lantern Pharma Inc. (Nasdaq: LTRN) is a clinical-stage biopharmaceutical company redefiningoncology drug development through artificial intelligence. ...

Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio

09 Sep 2025

Contributed by Lukas

Foremost Clean Energy (Nasdaq: FMST) is a rapidly growing North American uranium exploration holding an option to earn up to a 70% interest in 10 unde...

PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth

26 Aug 2025

Contributed by Lukas

Phoenix Motor (OTC: PEVMD) is a pioneer and emerging leader in the electric vehicle (“EV”) industry, designing, building, and integrating electric...

Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential

19 Aug 2025

Contributed by Lukas

60 Degrees Pharmaceuticals (Nasdaq: SXTP) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied ...

Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe

12 Aug 2025

Contributed by Lukas

Aptevo Therapeutics Inc. (Nasdaq: APVO) is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies through its pr...

Investor Insights: Calidi CEO Eric Poma Discusses Breakthroughs in Oncolytic Virotherapy

05 Aug 2025

Contributed by Lukas

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system...

Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma

29 Jul 2025

Contributed by Lukas

Lantern Pharma Inc. (Nasdaq: LTRN) is a clinical-stage biopharmaceutical company redefining oncology drug development through artificial intelligence....

Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook

22 Jul 2025

Contributed by Lukas

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company advancing (Z)-endoxifen, a next-generation selective estrogen r...

Inside Processa Pharma: CEO George Ng on Disrupting Oncology Drug Development

15 Jul 2025

Contributed by Lukas

Processa Pharmaceuticals (Nasdaq: PCSA) is a clinical-stage pharmaceutical company focused on developing the Next Generation Cancer (NGC) drugs with i...

Greenwich LifeSciences' CEO on Advancing HER2+ Immunotherapy | Phase III Insights & Strategy

08 Jul 2025

Contributed by Lukas

Greenwich LifeSciences (Nasdaq: GLSI) is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent bre...

How Fathom Holdings Is Disrupting Real Estate with Tech & Flat-Fee Innovation | CEO Marco Fregenal

01 Jul 2025

Contributed by Lukas

Fathom Holdings Inc. (Nasdaq: FTHM) is a technology-driven real estate services platform revolutionizing the traditional brokerage model. Through its ...

ASP Isotopes CEO Paul Mann on Transforming Global Isotope Supply for Medicine, Clean Energy, & More!

24 Jun 2025

Contributed by Lukas

ASP Isotopes is an advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industr...

Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive

17 Jun 2025

Contributed by Lukas

Enlivex (Nasdaq: ENLV) is a clinical stage macrophage reprogramming immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell ther...

Inside 60 Degrees Pharma: CEO Geoffrey Dow on Fighting Infectious Diseases & Driving Growth

10 Jun 2025

Contributed by Lukas

60 Degrees Pharmaceuticals (Nasdaq: SXTP) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied ...

Uranium & Lithium Boom: Foremost Clean Energy CEO on the Future of North America's Supply

03 Jun 2025

Contributed by Lukas

Foremost Clean Energy Ltd. (Nasdaq: FMST) (CSE: FAT) (WKN: A3DCC8) is a rapidly growing North American uranium and lithium exploration company. The Co...

FatPipe (Nasdaq: FATN) CEO Talks Profitability, Patented Tech & Global Growth Strategy

27 May 2025

Contributed by Lukas

FatPipe, Inc. (Nasdaq: FATN) is a pioneer in secure, software-defined networking technologies that simplify and fortify enterprise connectivity. The c...

BioVie CEO Cuong Do on Alzheimer’s Breakthroughs, Liver Disease Pipeline & What’s Ahead

20 May 2025

Contributed by Lukas

BioVie (Nasdaq: BIVI) is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver diseas...

Liberty Star Minerals: Leadership Breaks Down High-Grade Gold & Copper Potential in Arizona

13 May 2025

Contributed by Lukas

Liberty Star Minerals (OTCQB: LBSR) is a U.S.-based mineral exploration company focused on advancing high-potential copper and gold projects in Arizon...

Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment

06 May 2025

Contributed by Lukas

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company advancing (Z)-endoxifen, a next-generation selective estrogen r...

Inside ConnectM: How AI Is Powering the $2 Trillion Electrification Boom

29 Apr 2025

Contributed by Lukas

ConnectM Technology Solutions (Nasdaq: CNTM) is enabling a faster, smarter transition to an all-electric future through its AI-driven energy intellige...

bioAffinity (Nasdaq: BIAF) CEO Maria Zannes Talks CyPath® Lung, Growth & AI Innovation

22 Apr 2025

Contributed by Lukas

bioAffinity Technologies (Nasdaq: BIAF) addresses the urgent need for noninvasive, accurate early-stage cancer diagnosis and broad-spectrum cancer tre...

Interview with Connect Biopharma CEO Barry Quart | Transforming Acute Asthma & COPD Care

15 Apr 2025

Contributed by Lukas

Connect Biopharma Holdings Ltd. (Nasdaq: CNTB) is a clinical-stage biotechnology company advancing innovative therapeutics designed to transform the t...

BullFrog AI CEO Vin Singh on Revolutionizing Drug Development with AI-Powered Insights

08 Apr 2025

Contributed by Lukas

BullFrog AI, a US-company headquartered in Maryland, is revolutionizing drug discovery and development with BullFrog Data Networks®, a cutting-edge p...

LiveOne (Nasdaq: LVO) CEO Robert Ellin on Disrupting Music, Media & Monetization

01 Apr 2025

Contributed by Lukas

Headquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an award-winning, creator-first, music, entertainment, and technology platform focused on d...

Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential

25 Mar 2025

Contributed by Lukas

Nexalin Technology is a pioneering medical technology company focused on addressing the global mental health crisis through innovative neurostimulatio...

Inside Knightscope (Nasdaq: KSCP): CEO William Santana Li on AI, Robotics & Crime Prevention

18 Mar 2025

Contributed by Lukas

Knightscope (Nasdaq: KSCP) is transforming public safety with cutting-edge robotics and AI technologies. From autonomous security robots to advanced d...

Jupiter Neurosciences CEO Christer Rosén on Advancing Neuroinflammation Treatments & Beyond

11 Mar 2025

Contributed by Lukas

Jupiter Neurosciences, Inc. (Nasdaq: JUNS) is a clinical-stage pharmaceutical company pioneering treatments for neuroinflammation and rare diseases th...

Alliance Entertainment: Inside The Billion-Dollar Giant Powering Media Distribution Globally

04 Mar 2025

Contributed by Lukas

Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailer...

Inside Calidi Biotherapeutics: CFO Andrew Jackson Breaks Down the Future of Oncolytic Virotherapy

25 Feb 2025

Contributed by Lukas

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system...

60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoffrey Dow on Expanding Malaria Prevention & Beyond

18 Feb 2025

Contributed by Lukas

60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research ...

Elevating Fan-Owned Live Entertainment: VENU Founder & CEO J.W. Roth Shares His Disruptive Approach

04 Feb 2025

Contributed by Lukas

Venu Holding Corporation (NYSE American: VENU), founded by Colorado Springs entrepreneur J.W. Roth, is a premier hospitality and live music venue deve...

ASP Isotopes CEO Paul Mann on Breakthrough Isotope Tech, Quantum Computing & 2025 Growth Plans

28 Jan 2025

Contributed by Lukas

ASP Isotopes (Nasdaq: ASPI) is an advanced materials company dedicated to the development of technology and processes to produce isotopes for use in m...

Inside Enlivex: Oren Hershkovitz on Tackling Sepsis, Osteoarthritis, and Beyond with Allocetra™

07 Jan 2025

Contributed by Lukas

Enlivex (Nasdaq: ENLV) is a clinical stage macrophage reprogramming immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell ther...

Inside Gorilla Technology: CEO Jay Chandan & Interim CFO Bruce Bower on Smart Cities & Big Data

17 Dec 2024

Contributed by Lukas

Gorilla Technology Group (Nasdaq: GRRR) is a global leader in AI-based IIOT (Industrial Internet of Things) solutions with a strong emphasis on securi...

Inside OKYO Pharma’s (NASDAQ: OKYO) Phase 2 Trials with CEO Dr. Gary Jacob

03 Dec 2024

Contributed by Lukas

OKYO Pharma Limited (NASDAQ: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of DED and NCP, wit...

Inside VSee Health’s Telehealth Revolution: Exclusive Interview with Co-CEO Dr. Imo Aisiku

26 Nov 2024

Contributed by Lukas

VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programmin...

Inside Can-Fite BioPharma’s (NASDAQ: CANF) Clinical Pipeline with CEO Motti Farbstein

19 Nov 2024

Contributed by Lukas

Can-Fite BioPharma is an advanced clinical stage drug development company with a platform of oral drugs designed to address multi-billion-dollar marke...

How MUSQ ETF is Reshaping Music Investments: CEO David Shulhof Explains

12 Nov 2024

Contributed by Lukas

The MUSQ Global Music Industry ETF (MUSQ) offers investors focused exposure to the growing global music industry. The fund aims to replicate the perfo...

The Future of Oncology: Calidi’s Stem Cell-Based Platforms for Fighting Cancer

22 Oct 2024

Contributed by Lukas

Calidi Biotherapeutics (NYSE American:CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system ...

How Alliance Entertainment (Nasdaq AENT) is Optimizing Operations for Continued Margin Improvement

08 Oct 2024

Contributed by Lukas

Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailer...

The Gold Rush of 2024: Christopher Gerteisen’s Vision for Nova Minerals and Beyond

01 Oct 2024

Contributed by Lukas

Nova Minerals Limited is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project, comprise...

Interview with Founder of MUSQ Global Music Industry ETF

24 Sep 2024

Contributed by Lukas

Tracking the MUSQ Global Music Industry Index (MUSQIX), the MUSQ Global Music Industry ETF (NYSE: MUSQ) includes publicly traded companies with core i...

CEO Interview: ASP Isotopes is Commercializing New Isotope Enrichment Technology

17 Sep 2024

Contributed by Lukas

ASP Isotopes harnesses two decades of research and development to produce a broad range of isotopes, serving the expanding needs of nuclear medicine a...

CEO Interview: Discover How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market

03 Sep 2024

Contributed by Lukas

OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of DED and NCP, wit...

Learn Why Soligenix has Received $60M+ in Non-Dilutive Funding From the US Government: CEO Interview

20 Aug 2024

Contributed by Lukas

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Pioneering New Osteosarcoma and Breast Cancer Treatments: Exclusive Interview with OS Therapies' CEO

13 Aug 2024

Contributed by Lukas

OS Therapies (OSTX), a clinical stage biopharmaceutical company, is at the forefront of developing innovative treatments for Osteosarcoma (OS), breast...

CEO INTERVIEW: American Resources Corporation's Unique Ability to Refine Critical Elements

06 Aug 2024

Contributed by Lukas

American Resources Corp. (NASDAQ: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the n...

GreenPower Leverages Government Mandates and Funding to Boost Zero-Emission School Bus Line Growth

30 Jul 2024

Contributed by Lukas

GreenPower Motor Company is advancing the adoption of electric vehicles (EVs) by making all-electric buses and trucks affordable, durable and easy to ...

Discover Nexalin's Neurostimulation Device Targeting Mental Health Disorders

23 Jul 2024

Contributed by Lukas

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All Nexalin’s p...

Biotricity CEO, Waqaas Al-Siddiq, on New Heart Health Innovations & the Future of Cardiac Care

16 Jul 2024

Contributed by Lukas

Biotricity is transforming the healthcare market by bridging the gap in remote monitoring and chronic care management with a focus on cardiology. Phys...

Hope for Lung Cancer Patients: Cypath Lung Test's Impact

09 Jul 2024

Contributed by Lukas

bioAffinity Technologies, Inc. (NASDAQ: BIAF) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-sp...

Alta Global Group: Converting MMA fans into Participants. An Interview with CEO Nick Langton

02 Jul 2024

Contributed by Lukas

In this exclusive interview, we sit down with the CEO of Alta Global Group (MMA) to uncover how they're transforming the world of MMA training. Discov...

Exploring Can-Fite BioPharma's Groundbreaking Drugs: Piclidenoson and Namodenoson

14 May 2024

Contributed by Lukas

Can-Fite BioPharma is an advanced clinical stage drug development company with a platform of oral drugs designed to address multi-billion-dollar marke...

Unlocking Hope: The BioVie Journey in Neurodegeneration and Liver Disease

30 Apr 2024

Contributed by Lukas

BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration a...

AI Solutions in the Online CBD Industry: A 1606 Corp. Perspective

23 Apr 2024

Contributed by Lukas

1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation in the online CBD industry. With a clear mission to revolutionize customer ...

Spectaire Holdings (Nasdaq: SPEC) Launches AireCore System for Emissions Management!

09 Apr 2024

Contributed by Lukas

Spectaire Holdings (Nasdaq: SPEC) represents a pioneering leap in environmental technology with its flagship AireCore system, a game-changer in emissi...

Genetic Technologies: Innovating Healthcare with Genomics-based Cancer Predictions

02 Apr 2024

Contributed by Lukas

Genetic Technologies is executing a B2B commercialization strategy for its flagship geneType multi-risk test covering breast cancer, colorectal cancer...

Unlocking Growth: Exploring LOBO EV's Path to Market Leadership in E-Bikes and EVs

26 Mar 2024

Contributed by Lukas

LOBO EV presents an attractive value proposition underpinned by its strategic growth initiatives and solid performance across key segments. With an es...

Enlivex's (NASDAQ:ENLV) Allocetra™: Breakthrough Macrophage Reprogramming Therapy

19 Mar 2024

Contributed by Lukas

Enlivex presents a compelling investment opportunity in the biopharmaceutical sector with its innovative approach to treating life-threatening and deb...

Biotricity (NASDAQ: BTCY) Transforming Cardiac Care: Innovative Remote Monitoring Solutions

12 Mar 2024

Contributed by Lukas

Biotricity is revolutionizing cardiac care with its cutting-edge remote diagnostic and monitoring solutions that cater to a $35 billion total addressa...

Unlocking Growth: Lytus Technologies - Your Next Nasdaq Investment Opportunity in Digital & Healthcare Innovation!

05 Mar 2024

Contributed by Lukas

Lytus Technologies, a dynamic platform services company with a robust presence across India, boasts over four million active users, leveraging its str...

Biotricity (NASDAQ: BTCY) Revolutionizing Cardiac Care: Meet biotricity - Leading Remote Patient Monitoring Technology

27 Feb 2024

Contributed by Lukas

Biotricity is a pioneering medical technology company delivering a full suite of remote diagnostic and remote patient monitoring hardware solutions wh...

Xcel Brands (NASDAQ:XELB): Leading the Social Commerce Revolution

20 Feb 2024

Contributed by Lukas

Xcel Brands is a pioneering force in the convergence of shopping, entertainment, and social media and expects to generate $18 million in top-line roya...

1606 Corp. (OTC: CBDW): Revolutionizing CBD Customer Service with AI Innovation

13 Feb 2024

Contributed by Lukas

1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation in the online CBD industry. With a clear mission to revolutionize customer ...

Mobilicom (NASDAQ: MOB) Israel Ministry of Defense Purchases Mobilicom's Game-Changing Technology!

06 Feb 2024

Contributed by Lukas

Explore a Compelling Investment Opportunity with Mobilicom: Pioneers in the $34 Billion Drone Market! Mobilicom is at the forefront of the drone indu...

Meet Shalabh Gupta, CEO of Unicycive Therapeutics (NASDAQ: UNCY)

30 Jan 2024

Contributed by Lukas

We are a biotechnology company dedicated to developing treatments for certain medical conditions. Currently, we have two programs focused on kidney di...

The INNO (NASDAQ: INHD) Edge: Transforming Construction with Cold-Formed Steel Technology

25 Jan 2024

Contributed by Lukas

INNO Holdings is transforming the construction industry with its innovative approach to sustainable, efficient, and cost-effective building methods. U...

INNO Holdings Inc. (NASDAQ: INHD) - Redefining Construction with Steel Tech

09 Jan 2024

Contributed by Lukas

INNO Holdings is transforming the construction industry with its innovative approach to sustainable, efficient, and cost-effective building methods. U...

Genetic Technologies Limited (NASDAQ: GENE): Pioneering Genomics for Health and Wellness

02 Jan 2024

Contributed by Lukas

Genetic Technologies Limited (NASDAQ: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellnes...

bioAffinity Technologies: Exploring the Future of Cancer Care

26 Dec 2023

Contributed by Lukas

bioAffinity Technologies is an emerging player in early-stage cancer diagnosis and treatment. Its flagship product, CyPath® Lung, improves detection ...

Meet Maria Zannes: CEO of BioAffinity Technologies (NASDAQ: BIAF)

19 Dec 2023

Contributed by Lukas

bioAffinity Technologies is an emerging player in early-stage cancer diagnosis and treatment. Its flagship product, CyPath® Lung, improves detection ...

Innovation in Flight: Mobilicom's End-to-End Solutions for Drone Cybersecurity

05 Dec 2023

Contributed by Lukas

Mobilicom provides cybersecurity and robust solutions for drones and robotics. The Company is positioned to capture market leadership as the top end-t...

How Royalty Management Transforms Undervalued Assets

21 Nov 2023

Contributed by Lukas

Royalty Management Holding Corporation identifies and invests in highly undervalued assets in either growing or transitioning marketplaces in order to...

Meet Kirk Taylor: CFO of Royalty Management Holding Corporation (NASDAQ: RMCO)

14 Nov 2023

Contributed by Lukas

Royalty Management Holding Corporation (NASDAQ:RMCO) is a royalty company building shareholder value to benefit both our shareholders and communities ...

Meet Paul Mann: CEO & Chairman of ASP Isotopes

07 Nov 2023

Contributed by Lukas

ASP Isotopes, a leading isotope enrichment company, harnesses cutting-edge technology developed over two decades in South Africa to enrich isotopes of...